Posts tagged first-in-human clinical trial in Colombia
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device
PAVmed Selects Colombia for a First-in-Human Study on its PortIO™ Medical Device

PAVmed Inc. (Nasdaq:PAVM), is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. PAVmed has selected bioaccess.™ as its contract research organization (CRO) for a first-in-human clinical trial of its PortIO medical device. The clinical trial will be led by Dr. Jorge Humberto Ulloa —a leading vascular surgeon who trained at the Walter Reed Army Medical Center Washington DC— and will be conducted at Cirulaser Andes (“Cirulaser”) in Bogota, Colombia — a specialized vascular center affiliated with Hospital Universitario de la Fundación Santa Fé de Bogotá ("FSFB").

Read More
Clinical TrialsJulio G. Martinez-ClarkPAVmed, PortIO, Cirulaser Andes, Jorge Humberto Ulloa, first-in-human, first-in-human clinical trial in Colombia, first-in-human colombiaComment
Flow-FX Selects Colombia for a First-In-Human Clinical Trial on its Flow-Screw Medical Device for Delivery of Intraosseous (IO) Antibiotics
Flow-FX Selects Colombia for a First-In-Human Clinical Trial on its Flow-Screw Medical Device for Delivery of Intraosseous (IO) Antibiotics

Flow-FX, a Mokena, IL company poised to catalyze dramatic changes in orthopedic surgery with the ultimate goal of significantly improving patient outcomes, has selected Colombia and bioaccess™ as its contract research organization (CRO) for a first-in-human clinical study on its innovative Flow-Screw medical device for the delivery of intraosseous (IO) antibiotics. The study will be conducted at Clinical La Misericordia in Barranquilla, Colombia and will be led by Dr. Carlos Severini —chief of orthopedic surgery and trauma at Clinica La Misericordia and at Clinica Regional de la Policía Nacional, Mired IPS and university professor at Universidad Libre.

Read More
Clinical TrialsJulio G. Martinez-ClarkFlow-FX, first-in-human clinical trial in Colombia, Flow-ScrewComment
Hancock Jaffe Laboratories Selects bioaccess™ as CRO for its First-in-Human VenoValve® Study in Colombia
Hancock Jaffe Laboratories Selects bioaccess™ as CRO for its First-in-Human VenoValve® Study in Colombia

Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved standards of care for treating cardiac and vascular diseases, has selected bioaccess.™ as its contract research organization (CRO) for a first-in-human clinical trial of its VenoValve® bioprosthetic medical device. The clinical trial will be conducted at Hospital Universitario de la Fundación Santa Fé de Bogotá ("FSFB") in Bogota, Colombia. FSFB owns a 205-bed university hospital in Bogota, and was the first hospital in Colombia to receive the distinguished Joint Commission International accreditation; FSFB also boasts an academic affiliation with John’s Hopkins Medical International in Baltimore, MD.

Read More
Clinical TrialsJulio G. Martinez-ClarkHancock Jaffe Laboratories, CRO in Colombia, VenoValve, first-in-human clinical trial in ColombiaComment